Cure My Disease

Don't miss your cure!

 Log in / Sign up

New MRI technique could sharpen detection of active MS lesions

NCT ID NCT03268239

Completed Diagnosis Sponsor: Fondation Ophtalmologique Adolphe de Rothschild Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested two different MRI sequences to see which one better detects active inflammatory lesions in the brains of people with multiple sclerosis (MS). 180 adults with known central nervous system inflammatory disease who needed an MRI after a recent clinical event took part. The goal was to compare a 3D gradient-echo sequence against a 3D turbo-spin-echo sequence after contrast injection, to find the most sensitive method for spotting active lesions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to more accurate MRI detection of active MS lesions, helping doctors better diagnose and monitor the disease.
What could go wrong
This is a completed imaging study, not a treatment trial. The results may not change current practice if the new sequences do not prove significantly better.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain disorder central nervous system disorder demyelinating disease multiple sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRAIN CENTRAL NERVOUS SYSTEM DEMYELINATING DISEASES MAGNETIC RESONANCE IMAGING MULTIPLE SCLEROSIS

Contacts and locations

Locations

  • Fondation Ophtalmologique A. de Rothschild

    Paris, France, 75019, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.